MGF (Mechano Growth Factor) Peptide – User Manual & Research Protocol Guide

MGF (Mechano Growth Factor) is an isoform of insulin-like growth factor studied for its role in muscle repair signaling, cellular proliferation, and adaptive response to mechanical stress. In research environments, it is investigated for tissue regeneration, muscle recovery pathways, and anabolic signaling models.

Research Applications

Muscle repair and regeneration studies
Cell proliferation and differentiation research
Adaptive response to mechanical stress models
Anabolic signaling pathway investigations
Tissue recovery and growth factor research

Disclaimer: MGF is for research and experimental use only and is not FDA-approved for therapeutic use.

Lyophilized Powder
Freeze-dried MGF for reconstitution

Reconstituted Solution
Injectable research preparation after reconstitution

MGF is studied for its ability to:

• Support muscle satellite cell activation in experimental models
• Promote tissue repair signaling pathways
• Enhance cellular proliferation related to recovery processes
• Respond to mechanical stress-induced growth signaling
• Support regenerative physiology in laboratory settings

Observed effects are derived from preclinical and investigational research settings.

Subcutaneous (SC) – Standard Research Model

Typical research protocols use 100–300 µg per administration, generally once daily, often in recovery signaling research models.

Localized Research Model

Some studies use 100–200 µg following a study stimulus, typically for targeted tissue investigations.

Short-Course Research

Protocols may use 100–200 µg daily in limited-duration research studies.

Important

There is no approved human dosage. The ranges above reflect commonly cited research patterns only.

Initiation

A 1-week phase used for initial response observation at the beginning of the study.

Active Study Phase

Typically 2–4 weeks, focused on evaluating repair and growth-related pathways.

Rest Period

A 2–4 week interval between research cycles to allow recovery and system reset.

Note

Cycle duration may vary depending on the study design and research endpoints.

Supplies

Sterile bacteriostatic water
Sterile syringe
Alcohol swabs

General Procedure

1. Clean vial stopper with alcohol.
2. Add bacteriostatic water to desired concentration.
   Example: 2 mg vial + 1 mL → 2 mg/mL
3. Swirl gently to dissolve (do not shake).
4. Refrigerate at 2–8°C after reconstitution.
5. Use within 2–4 weeks or per protocol.

Maintain sterile handling technique
Rotate administration sites in injectable models
Document preparation concentration and date
Follow institutional research standards

Lyophilized Powder

Store in a cool, dry environment to maintain stability, with a shelf life of up to 12 months.

Reconstituted Solution

Keep refrigerated at 2–8°C and use within 2–4 weeks after preparation.

Protection Guidelines

Protect from light, heat, and contamination to preserve quality.

Safety Note

Discard the solution if it becomes cloudy or discolored, as this may indicate contamination or degradation.

Research use only
Not for therapeutic application
Human safety outside controlled research is not established
Potential research observations: injection-site irritation
Maintain sterile technique
Keep out of reach of unauthorized personnel

Peptide: MGF (Mechano Growth Factor)Category: Performance & Recovery ResearchDelivery: Injectable or localized research modelTypical Investigational Range: 100–300 µg per administrationCycle: 2–4 week research protocolsStorage: Refrigerated after reconstitution